Concentración y tamaño de las partículas de LDL tras el tratamiento con rosiglitazona en pacientes con diabetes mellitus tipo 2

After treatment with rosiglitazone, there is an increase of total cholesterol concentrations without variation in the mean size of LDL particles. Nevertheless, the reduction of CRP, and thus of inflammation is clear, with prevention of the progression of atherosclerosis.